Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Protons × Breast × Clear all

Phase

Phase 3 3 Phase NA 2 Phase 2/3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

HER2-positive Breast Cancer 1

Interventions

Trastuzumab 61 Paclitaxel 56 Cyclophosphamide 45 pembrolizumab 44 Carboplatin 35 Fulvestrant 34 Capecitabine 30 Docetaxel 28 Letrozole 23 Doxorubicin 19 palbociclib 17 Nivolumab 16 eribulin 15 durvalumab 15 130-nm albumin-bound paclitaxel 15 abemaciclib 14 Albumin-Bound Paclitaxel 14 sacituzumab govitecan 13 ribociclib 13 pertuzumab 13 Gemcitabine 13 Bevacizumab 12 olaparib 11 fludarabine 11 Vinorelbine 11 Taxes 11 Lapatinib 11 Filgrastim 11 atezolizumab 10 Everolimus 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02345772 2018-02-20

Neohttp

Western Regional Medical Center

Phase 1/2 Terminated

4 enrolled 1 chart

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡